Source: Annual Congress 2008 - Cell biology of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Calabrese, S. Baraldo, E. Bazzan, F. Lunardi, G. Turato, K. Lokar-Oliani, P. Sfriso, F. Rea, P. Maestrelli, A. Papi, R. Zuin, C. Dinarello, M. Saetta (Padova, Ferrara, Italy; Denver, United States Of America). Activation of IL-32 pathway in COPD. Eur Respir J 2008; 32: Suppl. 52, 354

Member's Comments

No comment yet.

Related content which might interest you: Activation of the inflammasome pathway during exacerbations of COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Caspase-1 pathway in COPD Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Analysis of cytokine signaling pathway JAK-STAT through their activation in patients with asthma Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Inhibition of VEGF blocks the activation of TGF-β1 through a PI3K/Akt signaling pathway in allergic airway disease of mice Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Activation of TGFβ/Smad signalling pathway in induced sputum of asthmatic children Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Role of RhoA/Rho-kinase pathway in the regulation of eNOS activity in COPD patients Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Inhibition of P38 kinase does not reduce production of TNF-alpha from airway cells in COPD Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 Hedgehog pathway activation is altered in COPD patients Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 The activation of NLRP3 inflammasome pathway in COPD is limited in local airways Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Inhibition of p38 mitogen-activated protein kinase has no effect on macrophage phagocytosis of bacteria in patients with COPD Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Upregulation of Suppressors of Cytokine Signalling (SOCS)3 in COPD alveolar macrophages. Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Endothelin-1 activates pro-inflammatory signalling pathway via destinct p38MAPK isoforms resulting in downregulation of nuclear p27kip1 Source: Annual Congress 2009 - Airway cell biology Year: 2009 In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020 Year: 2020 Induced sputum differential gene expression implicates increased p38 signalling activity in severe asthma Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Notch pathway signaling in asthma Source: Annual Congress 2006 - Markers of paediatric airway disease Year: 2006 JAK–STAT pathway activation in COPD Source: Eur Respir J 2015; 46: 843-845 Year: 2015 Cigarette smoke upregulates IL-8/CXCL8 expression by augmenting mRNA stability via p38 MAPK/MK2 signalling in normal human pulmonary cells Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012